Catherine Bresson

Director, Operational Team, WIN Consortium

Razelle Kurzrock

Chief, Division of Hematology & Oncology, Sr. Deputy Center Director for Clinical Science, University of California San Diego Moores Cancer Center (USA)

Vladimir Lazar

Chief Scientific and Operating Officer, WIN Consortium

Brian Leyland-Jones

Vice President of Molecular and Experimental Medicine, Avera Cancer Institute (USA)

John Mendelsohn

Director, Khalifa Institute for Personalized Cancer Medicine and Past-President, the University of Texas MD Anderson Cancer Center (USA)

Amir Onn

Head, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Richard L. Schilsky

Senior Vice President and Chief Medical Officer, American Society of Clinical Oncology (ASCO); Chairman, WIN

Josep Tabernero

Director and Clinical Research Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Apostolia-Maria Tsimberidou

Tenured Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Catherine Bresson

Director, Operational Team, WIN Consortium

Layla El-Gharras

Consultant, Operational Team, WIN Consortium

Vladimir Lazar

Chief Scientific and Operating Officer, WIN Consortium

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head, WIN IT Platform

Fanny Wunder

Project Manager, WIN Consortium

Andrea Califano

Chair of Department of Systems Biology, Columbia University (USA); Vice Chairman of WIN SAB

Sung-Min Ahn

Associate Professor, Division of Oncology, Department of Internal Medicine, Gachon University Gil Medical Center (South Korea)

Phillip Febbo

Chief Medical Officer, Illumina (USA)

Robert Grossman

Faculty, Senior Fellow, Searle Chemistry Laboratory, University of Chicago (USA)

Stanley R. Hamilton

Head of Pathology & Laboratory Medicine Labs, The University of Texas, MD Anderson Cancer Center (USA)

Leroy Hood

President and Co-Founder, Institute for Systems Biology (USA)

Pasi A. Jänne

Scientific Director, Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute (USA)

Yves Luisser

Associate Vice President for Health Sciences, The University of Arizona Cancer Center (USA)

John Quackenbush

Professor, Biostatistics & Computational Biology, Dana-Farber Cancer Institute (USA)

Gideon Rechavi

Head, Sheba Cancer Research Center, Chaim Sheba Medical Center (Israel)

Gary L. Rosner

Director, Division of Biostatistics and Bioinformatics, Department of Oncology, John Hopkins Medicine (USA)

Lillian Siu

Senior Staff Physician, Division of Medical Oncology and Hematology, Princess Margaret Hospital (Canada)

Alan Spatz

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

Yosef Yarden

Professor, Weizmann Institute of Science (Israel)

Gerald Batist

Professor & Chair, Department of Oncology, McGill University and Director, Segal Cancer Center (Canada)

Pierre Fumoleau

General Manager, Institut Curie Hospital Group, Paris (France)

Nicolas Girard

Head of Department, Medical Oncology, Institut Curie (France)

Razelle Kurzrock

Chief, Division of Hematology & Oncology, Sr. Deputy Center Director for Clinical Science, University of California San Diego Moores Cancer Center (USA)

Ulrik Lassen

Professor, Head of Phase 1 Unit, Rigshospitalet (Denmark)

Brian Leyland-Jones

Vice President of Molecular and Experimental Medicine, Avera Cancer Institute (USA)

Frank Makosiej

Executive Director, Operational Strategy and Planning, Clinical Development Services, Covance, Inc.(USA)

Jean-François Martini

Senior Director, Translational Oncology, Global Product Development-Oncology, Pfizer, Inc. (USA)

Amir Onn

Head, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Alejandro Piris

Scientific Research Manager, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Angel Porgador

Associate Professor, Ben-Gurion University of the Negev (Israel)

C.S. Pramesh

Chief, Thoracic Surgery, Division of Surgical Oncology, ACTREC - Tata Memorial Center (India)

Jacques Raynaud

President, Fondation ARC (France)

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head, WIN IT Platform

Richard L. Schilsky

Senior Vice President and Chief Medical Officer, American Society of Clinical Oncology (ASCO); Chairman, WIN

Benjamin Solomon

Asst Professor of Medicine, Avera Cancer Institute (USA)

Alan Spatz

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

Josep Tabernero

Director and Clinical Research Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)

George Wilding

Vice Provost, Clinical and Interdisciplinary Research, The University of Texas, MD Anderson Cancer Center (USA)

Ding-Wei Ye

Vice President International Affairs & Professor, Chairman of Department of Urology, Fudan University Shanghai Cancer Center (China)

Chang Sik Yu

President, Asan Medical Center Cancer Institute (South Korea)

Luis Eduardo Rosa Zucca

Medical Oncologist, Department of Clinical Oncology - Neoplasms Sector Genitourinary, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Taher Abu Hejleh

King Hussein Cancer Center (Jordan)

Mohammad Afshar

CEO, Ariana Pharmaceuticals (France)

Diana Aguirre

Senior Medical Director, Covance, Inc. (USA)

Amal Al Omari

Director, Office of Scientific Affairs and Research, King Hussein Cancer Center (Jordan)

Gerald Batist

Professor & Chair, Department of Oncology, McGill University and Director, Segal Cancer Center (Canada)

Guy Berchem

Medical Oncologist,Centre Hospitalier de Luxembourg (Luxembourg)

Raanan Berger

Director, Institute of Oncology, Sheba Medical Center (Israel)

Jean-Yves Blay

Professor of Medicine, Université Claude Bernard; Scientific Director, Canceropole Lyon Rhône Alpes, Centre Léon Bérard (France)

Rares Buiga

The Oncology Institute Ion Chiricuta (IOCN) (Romania)

David Cantú

Clinical Research, Instituto Nacional de Cancerologia (INCan)

Andrés Cervantes

Head of Section in Medical Oncology, INCLIVA (Spain)

Eun Kyung Cho

Department of Internal Medicine, Gachon University Gil Medical Center (South Korea)

Angela Davies

Chief Medical Officer, Champions Oncology Inc.(USA)

Francesco De Lorenzo

President, European Cancer Patient Coalition - ECPC (Belgium)

Franck Dufour

Scientific Director, Fondation ARC (France)

Matt Ellefson

Founder & CEO of SURVIVEiT®, (USA)

Trent Haywood

Chief Medical Officer, The Blue Cross and Blue Shield Association (USA)

Luis A. Herrera

Senior Researcher "C" of TC Definitivo of the Institute of Biomedical Research, Instituto Nacional de Cancerologia (INCan)

William Hwang

Medical Director, National Cancer Centre Singapore (Singapore)

Susan Galbraith

Senior Vice-President IMED Oncology, AstraZeneca, Cambridge, UK

Jean Claude Gerard

VP Commercial Operations Europe, HTG Molecular (France)

Nicolas Girard

Head of Department, Medical Oncology, Institut Curie (France)

Sadakatsu Ikeda

Junior Associate Professor, Deputy Director, Tokyo Medical and Dental University Cancer Center (Japan)

Alexandru Irimie

The University of Medicine and Pharmacy Iuliu Haţieganu (Romania)

Jennifer Jaskowiak

Director, Strategic Partnerships and Alliances Western Region, Champions Oncology Inc. (USA)

Timothy Johnson

President and Chief Executive Officer, HTG Molecular (USA)

Masashi Kanai

Associate Professor, Department of Clinical Oncology, Pharmacogenomics and Palliative Medicine, Graduate School of Medicine, Kyoto University Hospital (Japan)

Tae Won Kim

Director, Clinical Research Center & Center for Personalized Cancer Medicine (Korea)

Gautam Kollu

Head of Market Development, Illumina (USA)

Razelle Kurzrock

Chief, Division of Hematology & Oncology, Sr. Deputy Center Director for Clinical Science, University of California San Diego Moores Cancer Center (USA)

Tanel Laisaar

Head of Thoracic Surgery, Department of Pulmonology and Thoracic Surgery, Lung Clinic, Tartu University Hospital (Estonia)

Catherine Larue

CEO, Luxembourg Institute of Health (Luxembourg)

Ulrik Lassen

Professor, Head of Phase 1 Unit, Rigshospitalet (Denmark)

Brian Leyland-Jones

Vice President of Molecular and Experimental Medicine, Avera Cancer Institute (USA)

Scott M. Lippman

Director, University of California San Diego Moores Cancer Center (USA)

Frank Makosiej

Executive Director, Operational Strategy and Planning, Clinical Development Services, Covance, Inc.(USA)

Isabelle Manneh-Vangramberen

Head of Health and Research Programmes, European Cancer Patient Coalition - ECPC (Belgium)

Jean-François Martini

Senior Director, Translational Oncology, Global Product Development-Oncology, Pfizer, Inc. (USA)

Giorgio Massimini

Vice President, Head Medical Officer, New Businesses;Biopharma, Global Research & Development, Merck Group KGaA (Germany)

John Mendelsohn

Director, Khalifa Institute for Personalized Cancer Medicine and Past-President, the University of Texas MD Anderson Cancer Center (USA)

Ni Ming

Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)

Satoshi Miyake

Director, Tokyo Medical and Dental University Cancer Center (Japan)

Manabu Muto

Professor, Department of Therapeutic Oncology, Graduate School of Medicine, Head, Department of Clinical Oncology, Kyoto University Hospital (Japan)

Ioana Berindean Neagoe

Scientific Director, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)

Hovav Nechushtan

Associate Professor, Oncology Department, Hadassah Hebrew University Medical School (Israel)

Benjamin Neel

Director, Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center (USA)

Finn Cilius Nielsen

Professor and Head, Genomic Medicine, Rigshospitalet (Denmark)

Johannes Nippgen

R&D Program Lead & Clinical Lead - Erbitux, Merck Group KGaA (China)

Amir Onn

Head, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Iman Osman

Associate Director, Cancer Institute, Director, Interdisciplinary Melanoma Program, New York University Langone Medical Center (USA)

Peeter Padrik

Director of Cancer Centre, Tartu University Hospital (Estonia)

Prithwish Pal

Manager, Market Development, Oncology, Illumina (USA)

Tamar Peretz-Yablonski

Head Department of Oncology, Hadassah Medical Center (Israel)

Thierry Philip

Chairman of the Board of Directors, Institut Curie (France)

Alejandro Piris

Scientific Research Manager, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Angel Porgador

Associate Professor, Ben-Gurion University of the Negev (Israel)

C.S. Pramesh

Chief, Thoracic Surgery, Division of Surgical Oncology, ACTREC - Tata Memorial Center (India)

Eric Raymond

Head of Medical Oncology, Groupe Hospitalier Paris Saint-Joseph (France)

Jacques Raynaud

President, Fondation ARC (France)

Rui Manuel Reis

Coordinator, Molecular Oncology Research Center, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Gloria Ribas

Researcher, INCLIVA (Spain)

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head, WIN IT Platform

Pierre Saintigny

Laboratory of Translational Research, Department of Translational Research and Innovation, Centre Léon Bérard (France)

Marc Schlesser

Pneumologist, Pneumology Department, Centre Hospitalier de Luxembourg (Luxembourg)

Marina Sekacheva

Head of Center for Personalized Cancer Therapy, Sechenov First Moscow State Medical University (Russia)

Manju Sengar

Medical Oncologist and Officer in charge, Clinical Research Secretariat, ACTREC - Tata Memorial Center (India)

Dong Bok Shin

Department of Internal Medicine, Division of Hematology and Oncology, Gachon University Gil Medical Center (South Korea)

Lillian Siu

Senior Staff Physician, Division of Medical Oncology and Hematology, Princess Margaret Hospital (Canada)

Benjamin Solomon

Asst Professor of Medicine, Avera Cancer Institute (USA)

Jean-Charles Soria

Senior Vice President, Head of Oncology Innovative Medicines, MedImmune, USA

Alan Spatz

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

Andrey A. Svistunov

First Vice Rector for Innovation and International Affairs, I.M Sechenov First Moscow State Medical University (Russia)

Josep Tabernero

Director and Clinical Research Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Tira Tan

Consultant, Division of Medical Oncology, National Cancer Centre Singapore (NCCS)Singapore

Christof von Kalle

Director, Department of Translational Oncology, NCT and DKFZ (Germany)

George Wilding

Vice Provost, Clinical and Interdisciplinary Research, The University of Texas, MD Anderson Cancer Center (USA)

Casey Williams

Director of Molecular and Experimental Medicine, Avera Cancer Institute (USA)

Ding-Wei Ye

Vice President International Affairs & Professor, Chairman of Department of Urology, Fudan University Shanghai Cancer Center (China)

Chang Sik Yu

President, Asan Medical Center Cancer Institute (South Korea)

Luis Eduardo Rosa Zucca

Medical Oncologist, Department of Clinical Oncology - Neoplasms Sector Genitourinary, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)